p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors

BM Baron and BW Siegel

Merrell Dow Research Institute, Cincinnati, Ohio 45215.

Unlabeled p-iodoclonidine was efficacious in attenuating forskolin- stimulated cAMP accumulation in SK-N-SH neuroblastoma cells. Maximal attenuation was 76 +/- 3%, with an EC50 of 347 +/- 60 nM. Comparable values of epinephrine were 72 +/- 3% and 122 +/- 22 nM. Responses to both agonists were abolished by 10 microM phentolamine. Therefore, p- iodoclonidine is an agonist in a cell culture model system of the neuronal alpha 2-adrenergic receptor. p-[125I]Iodoclonidine binding to membranes were measured using various regions of the rat brain. The agonist labeled a single population of sites present on cerebral cortical membranes, which was saturable (Bmax = 230 fmol/mg of protein) and possessed high affinity for the ligand (Kd = 0.6 nM). Binding was largely specific (93% at 0.6 nM). A variety of alpha 2-adrenergic agonists and antagonists were shown to compete for the binding of the radioligand. The binding of p-[125I]iodoclonidine was much less sensitive to agents that interact with alpha 1-adrenergic, serotonergic, and dopaminergic receptors. Approximately 65% of the binding was sensitive to guanine nucleotides. Association kinetics using 0.4 nM radioligand were biphasic (37% associate rapidly, with kobs = 0.96 min-1, with the remainder binding more slowly, with kobs = 0.031 min-1) and reached a plateau by 90 min at 25 degrees. Dissociation kinetics were also biphasic, with 30% of the binding dissociating rapidly (k1 = 0.32 min-1) and the remainder dissociating 50-fold more slowly (k2 = 0.006 min-1). Agonist binding is, therefore, uniquely complex and probably reflects the conformational changes that accompany receptor activation.

Volume 38, Issue 3, pp. 348-356, 09/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. H. Wilson, H. A. Highfield, and L. E. Limbird The Role of a Conserved Inter-Transmembrane Domain Interface in Regulating {alpha}2a-Adrenergic Receptor Conformational Stability and Cell-Surface Turnover Mol. Pharmacol., April 1, 2001; 59(4): 929 - 938. [Abstract] [Full Text]

				K. M. Small, K. M. Brown, S. L. Forbes, and S. B. Liggett Polymorphic Deletion of Three Intracellular Acidic Residues of the alpha 2B-Adrenergic Receptor Decreases G Protein-coupled Receptor Kinase-mediated Phosphorylation and Desensitization J. Biol. Chem., February 9, 2001; 276(7): 4917 - 4922. [Abstract] [Full Text] [PDF]